CBMOS Selects INTEGRA Media Preparator
Researchers at the Centro Biología Molecular Severo Ochoa (CBMSO) in Madrid, Spain have demonstrated how the MEDIACLAVE Media Preparator and the DOSE IT Peristaltic Pump from INTEGRA can significantly enhance the efficiency and reproducibility of fly food preparation.
Drosophila melanogaster, the common fruit fly, is a commonly used model research organism in genetics, physiology and evolutionary development biology. Successful experiments using Drosophila typically depend on optimal husbandry and on providing good fly food quality. In some Drosophila labs, hundreds of vials are filled each day with fly food.
Mercedes Dávila, Head of Media Preparation Services at CBMOS commented: “Using a basic media cooking pot approach we could not accurately control the temperature of our ‘fly food’ during preparation and had to stir the mixture manually using a ladle. Because of the high viscosity of the fly food our technicians found filling all the vials a time-consuming and tedious process and often the food quality vial to vial was not consistent.” She added: “Our subsequent purchase of a stirrer kettle helped to improve the fly food mixture quality. Preparing the food, however, was still much too slow because it took several hours to cool the mixture to dispensing temperature.”
CBMSO’s investment in an INTEGRA MEDIACLAVE 30 Media Preparator and a DOSE IT peristaltic pump finally was the solution to this problem. Reflecting on the advantages that CBMSO had gained from the INTEGRA system, Mercedes Dávila said: “Our MEDIACLAVE 30 gives us the possibility to prepare 30 L of fly food in only 95 min. The integrated cooling system makes the process much faster than previous solutions.” She continued: “We can now keep the fly food mixture at the desired dispensing temperature. This allows us to dispense the food directly from the cuvette into the vials, without risking contamination or premature solidification inside the dispensing tubing”. Concluding, Mercedes Dávila said: “The electronic or paper process documentation from the INTEGRA system has enabled us to have standardized methods and fully traceable quality”.
To watch the MEDIACLAVE and DOSE IT being used for preparing fly food please visit www.youtube.com/watch?
For further information on the MEDIACLAVE 30 media preparation system and DOSE-IT peristaltic pump please visit www.integra-biosciences.com/
Related News
-
News Eli Lilly’s Alzheimer’s drug receives approval from US FDA
After facing several hurdles on its path to approval last year, Eli Lilly’s donanemab treatment for early Alzheimer’s, brand name Kisunla, received US FDA approval this past week. It is the second therapy for slowing the progression of Alzh... -
News This week in GLP-1 drug headlines: Manufacturing investment and new market launches
As drugmakers race to put their own GLP-1 drug products forward as the next biggest thing in weight-loss, current products are making numerous headlines this week with a number of new developments in their commercialisation and approval. Discover the l... -
News Women in Pharma: Regulating equity across regional borders
In our monthly series focusing on women in the pharmaceutical industry, we interview leading experts in the pharmaceutical supply and value chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News Viral marketing for B2B pharma businesses: a CPHI Online case study
Discover how a Chinese chemical manufacturing company went viral on TikTok, and what their viral success means for the future of B2B digital marketing for the wider pharmaceutical industry and supply chain. -
News New Aurigene biologics facility opens in Hyderabad, India
Aurigene Pharmaceutical Services Ltd. have opened a biologics facility in Hyderabad, India in a biocluster known as Genome Valley. -
News Novo Nordisk launches 'Power of Wegovy' national campaign
Danish drugmaker Novo Nordisk have launched a new national campaign – The Power of Wegovy – that aims to educate those living with obesity on their blockbuster drug Wegovy throughout the United States. -
News Women in Pharma Anniversary: Celebrating Our Heroines of Pharma
Our Women in Pharma interview series is approaching its 1-year anniversary this month, and to celebrate, we are highlighting the Heroines of Pharma that our very own Women in Pharma admire. -
News Sanofi gains rare disease therapy in acquisition of Inhibrx for US$1.7 billion
Sanofi completed the acquisition of the clinical-stage biotech company Inhibrx in late May 2024 after settling on a US$1.7 billion buyout. The acquisition brings with it a rare disease therapy to bollster Sanofi's pipeline.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance